Document Details

MGEN $3.51 $ - 0.13 (3.57%)
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 8/7/2018
Filing Date 8/7/2018

Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
Download

File Section(s)

  1. FORM 8-K
  2. EX-99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.